086040 — Biotoxtech Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩48bn
- KR₩83bn
- KR₩47bn
Annual cashflow statement for Biotoxtech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,980 | 1,512 | -8,950 | -12,657 | -1,573 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,227 | 3,467 | 2,212 | 8,515 | -1,565 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,078 | -8,232 | -13,179 | -7,076 | 5,442 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,346 | -1,309 | -16,238 | -7,120 | 6,636 |
| Capital Expenditures | -7,956 | -30,785 | -4,883 | -2,381 | -2,232 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 199 | 4,387 | 2,904 | -7,459 | 8,415 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7,757 | -26,399 | -1,978 | -9,841 | 6,183 |
| Financing Cash Flow Items | -181 | -5.43 | 216 | -227 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19,279 | 21,929 | 33,022 | 762 | -5,489 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15,845 | -5,892 | 14,779 | -16,109 | 7,262 |